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Purpose: Oculomotor disorders have been reported in multiple sclerosis (MS) in up to 80% 
of cases. There have been studies evaluating binocular vision in several neurological 
diseases, but not in MS. Considering that a high percentage of eye-movement anomalies 
have been reported, the aim of this study was to analyze binocular vision in these subjects.
Methods: A total of 59 participants with MS — 21 with monocular optic neuritis, eleven 
with binocular optic neuritis, and 27 without optic neuritis — and 26 age-matched controls 
were enrolled. Binocular vision was analyzed using near point of convergence (NPC), 
positive and negative fusional vergence for far and near distance, measurement of hetero-
phoria at both distances with cover and modified Thorington tests, and random-dot 
stereoscopy.
Results: The percentage of subjects with abnormal NPC values was highest in the MS 
group, followed by the MSONm (MS with optic neuritis in one eye), MSONb (MS with 
optic neuritis in both eyes), and control groups. MS patients showed an esophoric trend at 
near distance. Positive fusional vergence showed no significant differences between control 
and MS groups, but higher variability in recovery was found in MS groups. Negative 
fusional vergence at near distance showed significant differences between the control 
group and the two MS groups, with optic neuritis for both break-point and recovery values. 
A high percentage of patients with MS had alterations on stereopsis.
Conclusion: Alterations in binocular vision were present in MS, with divergence at near 
distance and stereopsis the most affected parameters. Likewise, MS patients with optic 
neuritis showed worse binocular vision.
Keywords: multiple sclerosis, binocular vision, near point of convergence, heterophoria, 
fusional vergences, stereopsis
Introduction
Multiple sclerosis (MS) is defined as a neurodegenerative central nervous system 
disease associated with the presence of inflammatory localized lesions causing 
myelin loss.1–3 It is more prevalent in women than in men, and produces disability 
in young adults behind traumatic lesions.
The visual system is severely affected by MS, and some visual symptoms 
have been found to be associated with these patients, such as affected of low- 
contrast visual acuity, visual field, or color perception.4–6 Optic neuritis (ON) is 
a common disorder associated with these patients, and is present in up to 50% 
of subjects with MS during the course of the disease.7 Most vision-related 
symptoms in MS can be attributed to present or resolved ON in this population, 
but some of these findings are present even if no ON has been suffered.8 
Therefore, ophthalmological and optometric evaluation is essential in the follow- 
up of patients with MS.
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Localized lesions of MS can involve a large part of the 
visual pathway, and may lead to problems in oculomotor 
activity.9 Oculomotor disorders, such as saccadic dysme-
tria, impaired smooth pursuit, nystagmus, and impaired 
convergence,10–12 have been reported in MS in up to 
80% of cases. These alterations can appear as the first 
symptom of the disease, but can can show up in relapse 
and even in the course of the MS.13 Moreover, these 
alterations in oculomotricity have been associated with 
high levels of disability, with a negative impact on quality 
of life.14 Likewise, fatigue, defined as a sense of exhaus-
tion, lack of energy, or tiredness, is present in at least 75% 
of patients,15 with potential involvement of extraocular 
muscles and consequently the possibility of generating 
alterations in oculomotricity.
There have been studies evaluating oculomotricity and 
binocular vision in several neurological diseases, such as 
Parkinson’s, spinocerebellar ataxia, Huntington’s, multi-
ple-system atrophy and Alzheimer’s,16,17 but not in MS. 
A high percentage of eye-movement anomalies have been 
reported in patients with MS due to the demyelination 
process of the neural substrate of ocular muscles, and 
affected binocular vision could be another visual conse-
quence of the MS, as occurs in other neurodegenerative 
diseases. Due to the scarce scientific literature in this 
regard, the aim of this study was to explore binocular 
vision in patients with MS and report the presence of 
abnormal results in comparison to healthy controls.
Methods
Subjects
Subjects were recruited from two clinical centers: the 
Optometric Clinic of the Lluis Alcanyis Foundation 
(University of Valencia, Valencia, Spain) and the 
Optometric Clinic of the University of Alicante (Alicante, 
Spain). All participants signed a written informed consent 
prior to inclusion in the study and after being informed 
about its nature according to the tenets of the Declaration 
of Helsinki. The protocol was approved by the ethics com-
mittees of the University of Alicante (UA-2018-03-02) and 
University of Valencia (H1527574656645).
Patients with MS were included regardless of duration 
of disease, age at onset, or type of MS. Subjects had been 
previously diagnosed and followed by their neurologists 
and were recruited from local associations. Patients with 
ocular disorders before the diagnosis of MS were 
excluded, but a high percentage had had resolved ON 
during the course of the disease. Patients with MS, both 
with and without previous ON, were included, but subdi-
vided into three groups: MS group (MS without ON), 
MSONm (MS with ON in one eye), and MSONb (MS 
with ON in both eyes).
Although subjects had no strabismic alterations and 
thus had a priori presence of binocular vision (almost 
simultaneous vision), they were not exempt from suffering 
nonstrabismic alterations on functionality (eg, asympto-
matic reduced near fusional vergence). Likewise, the pre-
sence of nonstrabismic binocular alterations in the MS 
groups could have been due to normal prevalence and 
not caused by the disease. Since diagnosis of nonstrabis-
mic binocular vision alterations depends on the criteria 
selected and there is no agreement on normal values for 
studied parameters in the presbyopic population,26 the 
results obtained in MS groups were compared with those 
obtained in an age- and sex-matched control group to 
evaluate prevalence in relative terms.
The control group comprised on healthy subjects (with-
out any active ocular pathology) and without strabismus or 
amblyopia (without strabismic binocular vision altera-
tions) that had been enrolled randomly as a reference 
population. Subjects with refractive errors wore their best 
corrected–refraction spectacles and were measured with 
compensation for distance/near vision. Binocular examina-
tion was evaluated following the order described in the 
next section.
Procedure
Near Point of Convergence
Near point of convergence (NPC) without accommodative 
stimulus was measured in all subjects.18 A sharpened tip 
of a pencil was placed 40–50 cm from the patient’s eyes in 
the primary gaze, and then the examiner slowly moved the 
target toward the patient’s eyes. The patient was instructed 
to report when the target appeared double or split into two. 
At this point, the examiner stopped moving the pencil and 
measured the distance from the target to the patient’s eye 
in centimeters, and this was the NPC break point. If the 
patient did not report double vision, but the examiner saw 
that one eye had lost fixation and deviated, that position 
was considered the NPC break point. The examiner then 
moved the target away along the same path until single 
vision was reported and this distance was also measured, 
corresponding to the NPC-recovery point. Difference 
between break and recovery distance, defined as NPC- 
recovery range, was also calculated and averaged.
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Horizontal Heterophoria
To evaluate ocular alignment and detect the presence of 
horizontal heterophoria, two free-space methods were con-
sidered: the cover test19 (objective method in which the 
examiner assesses the presence and level of misalignment) 
and the modified Thorington test20 (subjective method 
based on patient-reported perception). The cover–uncover 
test was carried out to determine if there was strabismus, 
whereas the alternating cover test was used to quantify the 
magnitude of the deviation. This measurement was per-
formed for far and near distance (4 m and 40 cm, respec-
tively). The modified Thorington test was performed by 
positioning a red Maddox rod over the right eye and 
asking the patient about the number at which the red line 
crossed while he/she was fixating on a light stimulus 
arranged in the center of the card. This measurement was 
performed for far and near distance (2 m and 40 cm, 
respectively). Both tests were conducted on primary gaze 
position. Positive values represented esophoria and nega-
tive values exophoria.
Fusional Vergence
Positive and negative fusional vergence21 were measured 
using a horizontal prism bar (Gulden B-16, horizontal 
1Δ–45Δ) and a handheld fixation target containing 
a single vertical column of letters of 20/32 visual acuity 
for far and near distance (4 m and 40 cm, respectively). 
Each subject was asked to report when the letters became 
double (split into two). This was defined as the break 
value. Then, prismatic demand was reduced until single 
vision was restored. This was defined as the recovery 
value. Negative fusional vergence was measured firstly 
to avoid excessive stimulation of convergence in recov-
ery from positive fusional vergence measures.22 
Differences between break and recovery values, defined 
as recovering ranges, were also calculated and averaged.
Stereopsis
Stereopsis was measured using the Randot preschool 
stereoacuity test (Stereo Optical, Chicago, IL, USA).23 
This test was administered and scored (from 40 to 800 
arc seconds) according to the manufacturer’s instructions. 
If stereopsis were immeasurable, the Worth four-dot test24 
in a darkened room was used to assess if the subject were 
able to see five dots, confirming the perception of diplopia, 
or two red or three green dots, indicating the presence of 
suppression in one eye. For analytical purposes, results 
were recorded as proposed by Webber et al25 and 
binocular function obtained as the logarithmic value of 
the threshold obtained in seconds of arc. For example, 
a stereopsis value of 200 arc seconds was scored as 
log200=2.3. A fixed score of four was assigned when 
diplopia was present, and a score of five in cases of 
suppression.
Statistical Analysis
Statistical analyses were performed using SPSS 26.0.0. 
The Shapiro–Wilk test revealed no parameters followed 
normal distribution, so nonparametric tests were applied. 
Differences between groups (control, MS, MSONm, and 
MSONb) were analyzed with the Kruskal–Wallis test for 
NPC (break point, recovery point, and range), cover test, 
modified Thorington test, PFV, and NFV (break point, 
recovery point, and range), and stereopsis (expressed as 
logarithmic value). For parameters showing differences 
between groups, additional Mann–Whitney paired analysis 
(with Bonferroni adjustment) was done. Three measure-
ments were obtained from every studied parameter, and 
the average value was analyzed. During the acquisition of 
some parameters, subjects with MS seemed to be more 
variable on their responses. Intrasubject standard deviation 
of PFV and NFV was analyzed to represent the variability 
of the three consecutive measures.
Although participants had no strabismic binocular 
alterations, they were not exempt from suffering accom-
modative and nonstrabismic binocular dysfunction, ie, we 
could not assume that subjects were binocularly normal, so 
all groups were compared with normal values provided in 
the literature and the percentage of subjects with abnormal 
values in each group compared. There is no agreement on 
diagnostic criteria for binocular dysfunction in the scien-
tific literature,26 but our purpose was not diagnosis but 
comparison between groups, so a specific criterion for 
each studied parameter was chosen. The percentage of 
eyes with exophoria, orthophoria, or esophoria measured 
by the cover and modified Thorington tests is also reported 
for all groups.
Results
A total of 59 subjects with MS and 26 age-matched 
healthy subjects were recruited: 27 in the MS group, 21 
in the MSONm group, and eleven in the MSONb group. 
From the initial sample of 68 subjects, nine were excluded 
from analysis of NPC, horizontal heterophoria, PFV, and 
NFV, due to the presence of suppression in one eye (one in 
the MS group, five in the MSONm group, and three in the 
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MSONb group). All patients were considered for analysis 
of stereopsis outcomes, since the scoring system used20 
allowed the inclusion of patients without measurable 
stereopsis values.
The mean age of subjects was 49±10 years (20 women 
and seven men) in the MS group, 50±9 years (13 women 
and six men) in the MSONm group, 50±7 years (nine 
women and two men) in the MSONb group, and 50±8 
years (16 women and ten men) in the control group. There 
were no statistically significant differences among groups 
regarding age (p=0.82) or sex (p=0.63). Mean refractive 
errors per group (spherical equivalent) were −0.30±1.31 
D in the control group, −0.29±2.76 D in the MS group, 
0.32±1.94 D in the MSONm group, and 0.17±2.03 D in 
the MSONb group (p=0.42). All participants in both con-
trol and study groups achieved a good corrected logMAR 
visual acuity with no statistically significant differences 
among groups (p=0.31): −0.08±0.06 in the control group, 
−0.03±0.08 in the MS group, 0.02±0.11 in the MSONm 
group, and 0.08±0.12 in the MSONb group. Means ± SD 
obtained for the parameters evaluated (ranges and intra-
subject SD) are summarized in Table 1. Abnormal results 
in each group are summarized in Table 2. Likewise, the 
percentage of eyes according to type of horizontal hetero-
phoria is summarized in Table 3.
Near Point of Convergence
Higher values for break point, recovery point, and range of 
NPC were found in the MSONm group than the MS and 
MSONb groups, the latter two with fairly similar values. 
The control group showed the best NPC results(Table 1). 
Although differences between groups did not reach statis-
tical significance for break or recovery points (p=0.61 and 
p=0.15, respectively), differences among groups in the 
range were close to significance (p=0.06).
To determine the percentage of subjects with abnormal 
NPC values, our results were compared to those of Scheiman 
et al18 and NPC break and recovery values of 5 cm and 7 cm, 
respectively, considered. The proportion of subjects with 
abnormal values on both break and recovery points 
(Table 2) was highest in the MS group (48%), followed by 
the MSONm (42%) and MSONb (36%) groups. The control 
group had the lowest proportion of subjects with abnormal 
NPC results (26%).
Horizontal Heterophoria
For far distance, both the cover and modified Thorington 
tests showed values close to orthophoria in the control, 
MS, and MSONb groups, whereas a trend toward eso-
phoria was found in the MSONm group (Table 1). For 
near distance, the cover test showed exophoric values for 
the control, MS, and MSONb groups, whereas a trend 
toward esophoria was found in the MSONm group. 
The modified Thorington test showed exophoric values 
for the control and MSONb groups, orthophoria for the 
MS group, and esophoria for MSONm group. Differences 
in heterophoria measurements with tests for far and near 
distance among groups did not reach statistical 
significance.
To determine the percentage of subjects with abnormal 
heterophoria, our results were compared to those of Cantó- 
Cerdán et al19 for the cover test and Lyon et al20 for 
the modified Thorington test. For far distance, normal 
values of −1±2∆ and 0±2∆ were considered, respectively. 
For near distance, normal values of −3±4Δ and −1±4Δ 
were considered, respectively. Results for subjects with 
abnormal horizontal heterophoria for far and near distance 
on both cover and modified Thorington tests are shown in 
Table 2.
Regarding the type of horizontal heterophoria reported 
(Table 3), percentages differed slightly between the cover 
and Thorington tests, due to differences in the grade of 
dissociation of both tests. In general, for both far and near 
distance, more esophoria was obtained in sclerosis groups 
than the control group.
Fusional Vergence
Positive fusional vergence measurements for far distance 
showed the highest values for both break and recovery 
points in the control group, whereas the MSONb group 
achieved the lowest values, as can be seen in Table 1. The 
ranges for far distance were similar in all groups, although 
the MSONb group showed a trend toward smaller ranges. 
No statistically significant differences were found between 
groups (p>0.05). Nevertheless, intrasubject SD corre-
sponding to break and recovery points differed signifi-
cantly between the control and MS groups (p<0.05). 
Positive fusional vergence measurements for near distance 
followed the same trend, with better values in the control 
group, but not reaching statistically significant differences 
between groups (p>0.05). Intrasubject SD corresponding 
to break and recovery points differed significantly when 
comparing MSONm and MS groups with the control 
group (p<0.05).
Negative fusional vergence measurements for far distance 
showed the highest values for both break and recovery points 
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Table 1 Means ± SD and Medians (IQR) of Parameters Analyzed in the Four Groups of Patients Evaluated Those Comparisons 
Obtaining Statistical Significance are Marked with an Asterisk. Exophoria was Included with Negative Sign and Esophoria with Positive. 
Sw: Intrasubject SD from Three Consecutive Measurements
Control MS MSONm MSONb p
Near point of convergence (cm) Break 3.60±3.74 5.20±4.41 6.11±7.06 5.31±6.53 0.61
4.00 (6.25) 6.00 (7.50) 4.00 (8.00) 4.50 (6.00)
Recovery 5.38±5.41 9.85±8.32 10.81±10.68 8.45±7.95 0.15
6.00 (10.25) 10.00 (15.00) 8.50 (15.00) 10.00 (10.50)
Range 1.76±1.96 4.64±4.92 4.70±5.10 3.13±2.42 0.06
1.50 (7.00) 4.00 (6.00) 3.00 (7.50) 3.00 (10.00)
Cover test (Δ) Distance −0.24±0.66 0.32±1.24 1.44±4.44 0.10±2.07 0.39
0 (2.00) 0 (0.00) 0 (1.00) 0 (3.00)
Near −2.88±4.62 −2.59±6.72 0.27±7.69 −2.82±7.27 0.70
−4.00 (8.00) −4.00 (10.00) −2.50 (11.00) −3.00 (7.00)
Modified Thorington test (Δ) Distance 0.12±0.75 0.40±2.76 1.63±5.10 −0.30±4.11 0.62
0 (4.00) 0 (1.50) 0 (4.30) 0 (3.10)
Near −2.18±3.21 0.00±7.58 1.50±5.19 −1.50±6.16 0.12
−3.00 (4.50) −1.00 (7.00) 0 (6.50) −0,50 (7.00)
Positive fusional vergence (Δ) Distance Break 18.74±5.94 16.73±8.22 17.50±7.40 14.90 ±8.57 0.38
17.33 (11.00) 14.66 (15.00) 19.33 (13.67) 14.00 (24.00)
Sw 0.84±1.46 1.93±2.34 3.52±3.32 2.54±1.97 0.002*
0 (1.15) 1.15 (3.06) 2.89 (3.58) 2.00 (3.85)
Recovery 11.92±4.53 10.83±5.43 11.51±5.59 10.09±6.21 0.67
11.00 (7.33) 8.66 (16.00) 13.33 (9.33) 9.33 (10.67)
Sw 0.48±0.66 1.93±1.63 2.84±2.90 1.70±1.41 <0.001*
0 (1.15) 2.00 (3.06) 2.00 (3.01) 1.15 (1.16)
Range 6.82±3.70 5.77±4.10 6.14±2.98 4.81±3.44 0.26
6.66 (6.00) 4.00 (7.00) 5.33 (4.67) 3.66 (4.33)
Near Break 23.73±9.87 19.64±11.18 23.00±7.86 17.69±9.91 0.24
23.33 (16.17) 18.66 (18.67) 22.00 (11.67) 14.66 (20.00)
Sw 1.23±1.25 3.67±4.49 3.57±2.47 1.32±1.40 0.002*
1.15 (2.89) 2.89 (5.03) 2.89 (2.98) 1.15 (2.89)
Recovery 18.91±8.71 15.20 ±10.29 15.82±6.82 12.03±9.67 0.28
18.00 (13.00) 14.00 (14.33) 14.66 (11.67) 10.66 (8.00)
Sw 0.68±0.96 2.48±1.93 2.98±1.78 0.83±0.94 <0.001*
0 (1.15) 2.31 (2.85) 2.89 (2.04) 1.00 (1.73)
(Continued)
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in the control group. Only the recovery point showed statisti-
cally significant differences between the three sclerosis groups 
and the control group (p<0.05 in all cases). Intrasubject SD 
showed a statistically significant difference between the MS 
and MSONm groups and the control group (p<0.05). 
Negative fusional vergence measurements for near distance 
showed significant differences between the control group and 
the two groups with ON for both break and recovery points 
(p<0.05). These results are summarized in Figure 1. Although 
there were no significant differences between the MS and 
control groups in near-distance break and recovery points 
(p>0.05), intrasubject SD differed significantly (p<0.05). No 
statistically significant differences between groups were 
found in the negative fusional vergence range (p>0.05).
To determine the percentage of subjects with abnormal 
positive and negative fusional vergence values, our results 
were compared to those of Lyon et al,20 and normal values 
of 12±7∆ (break point) and 7±5∆ (recovery point) were 
considered for positive fusional vergence, and of 8±4∆ 
(break point) and 5±3∆ (recovery point) for negative 
fusional vergence for far distance. For near distance, nor-
mal values of 20±11∆ and 14±8∆ were considered for 
positive fusional vergence and 13±6∆ (break point) and 9 
±4∆ (recovery point) for negative fusional vergence. 
Table 1 (Continued). 
Control MS MSONm MSONb p
Range 4.80±3.80 4.43± 4.29 7.17±4.53 5.66±2.24 0.06
4.50 (3.25) 4.00 (2.33) 6.33 (6.67) 5.00 (1.67)
Negative fusional vergence (Δ) Distance Break 7.43±2.36 6.15±2.14 7.12±3.40 6.54±3.55 0.15
7.33 (3.33) 6.00 (2.83) 6.00 (3.33) 5.33 (4.00)
Sw 0.48±0.57 0.89±0.74 1.08±0.99 0.73±0.58 0.02*
0 (1.15) 1.15 (1.15) 1.15 (1.15) 1.15 (1.15)
Recovery 5.17±2.32 3.43±1.61 3.64±2.04 2.69±1.44 0.003*
4.00 (7.33) 3.33 (2.00) 3.66 (8.67) 2.00 (2.33)
Sw 0.22±0.46 0.50±0.54 1.01±2.01 0.57±0.51 <0.001*
0 (1.15) 0.29 (1.15) 0 (1.15) 0.58 (1.15)
Range 2.25±1.33 2.71±1.99 3.48±1.85 3.84±3.59 0.01*
2.00 (1.50) 2.00 (0.75) 2.66 (0.17) 3.00 (1.67)
Near Break 13.46±3.81 10.81± 2.82 10.10±2.83 9.21±3.73 0.007*
13.33 (6.17) 10.66 (5.33) 10.00 (2.67) 10.00 (8.00)
Sw 0.53±0.58 1.27±0.87 2.03±2.61 1.29±0.90 0.002*
0 (1.15) 1.15 (0.85) 1.15 (1.91) 1.15 (0.85)
Recovery 10.58±3.70 7.91±2.80 6.19±3.29 6.03±3.04 0.001*
10.00 (4.67) 8.00 (5.33) 6.66 (5.33) 5.33 (5.33)
Sw 0.44±0.57 1.15±1.13 1.61±1.12 1.39±0.72 <0.001*
0 (1.15) 1.15 (1.15) 1.15 (1.16) 1.15 (0.85)
Range 2.87±1.78 2.90±1.08 3.91±1.85 3.18±1.55 0.10
2.33 (1.50) 2.66 (1.33) 3.33 (3.33) 2.66 (2.00)
Log stereopsis Near 1.70±0.12 2.09±0.64 2.59±1.20 3.04±1.21 <0.001*
1.69 (0.18) 2.00 (0.70) 2.00 (0.99) 2.30 (2.00)
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Percentages of subjects with abnormal values for far and 
near distance on both positive and negative fusional ver-
gence are shown in Table 2.
Stereopsis
Higher scores, indicating worst binocularity, were 
obtained in the MSONb group, followed by the 
MSONm and MS groups. The best stereopsis values 
were found in the control group, as shown in Table 1. 
There were significant differences between the control 
group and the three sclerosis groups (p<0.02 in all 
cases). Likewise, the MS group showed statistically 
significant differences in stereopsis when compared 
with the MSONb group (p=0.02), but not with the 
MSONm group (p>0.05). Statistically significant differ-
ences were also observed between the two groups with 
ON, as can be seen in Figure 2.
According to previous studies on healthy adults,27 an 
upper limit of 70 seconds of arc is considered normal. The 
percentage of subjects with abnormal stereoscopic values 
was highest in the MSONb group (100%), followed by the 
MSONm group (70.8%) and the MS group (53%). In the 
control group, only 7.7% of subjects showed an abnormal 
stereopsis value. Stereopsis was correlated with the magni-
tude of near-distance heterophoria in the MS group (r= 
−0.57, p=0.002).
Discussion
Neurodegenerative disorders affect the central nervous 
system, often leading to motor and sensorial problems. 
Eye-movement control is complex, and involves many 
brain areas that can be affected by demyelination, disturb-
ing the normal functioning of binocularity.9 Studies have 
reported alterations in vergence, saccades, and smooth 
pursuit in some demyelinating pathologies, such as 
Parkinson’s disease, spinocerebellar ataxia, Huntington’s 
disease, and multiple-system atrophy.16,17 However, 
although eye-movement disorders in MS have been widely 
Table 2 Binocular Abnormalities per Group Classified According to the Normative Values Described in the text. For Cover and 
Modified Thorington Tests Results Displayed Separately According to the Type of Heterophoria
Control, n=26 MS, n=27 MSONm, n=19 MSONb, n=11
Near point of convergence 7 (26%) 13 (48%) 8 (42%) 4 (36%)
Cover test Far 3 (11.5%) 4 (16%) 7 (35%) 4 (36.3%)
−3 exo 3 eso 1 exo 4 eso 3 exo 3 eso 1 exo
Near 6 (23%) 14 (53%) 9 (45%) 3 (28%)
6 eso 8 eso 6 exo 6 eso 3 exo 3 eso
Modified Thorington test Far 1 (3.8%) 9 (34.6%) 9 (45%) 5 (45.4%)
1 eso- 6 eso 3 exo 7 eso 2 exo 3 eso 2 exo
Near 5 (19.2%) 8 (30%) 6 (33.3%) 4 (40%)
3 eso 2 exo 5 eso 3 exo 6 eso 3 eso 1 exo
Positive fusional vergence Far Break 4 (15%) 12 (44%) 12 (52%) 5 (45.5%)
Recovery 1 (3.8%) 3 (11%) 1 (5%) 3 (27%)
Near Break 5 (19.2%) 11 (40.4%) 4 (21%) 5 (45.4%)
Recovery 2 (7.6%) 4 (14.8%) 1 (5.6%) 4 (36.3%)
Negative fusional vergence Far Break 4 (15%) 10 (37%) 6 (31.5%) 6 (54.5%)
Recovery 0 5 (19%) 3 (16%) 4 (36%)
Near Break 21 (80%) 27 (100%) 19 (100%) 11 (100%)
Recovery 3 (11.5%) 10 (38.4%) 10 (52.6%) 8 (72.7%)
Stereopsis 2 (7.7%) 15 (53%) 17 (70.8%) 11 (100%)
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described in the literature,3,8–10,12,13 there have been no 
studies to date on NPC, horizontal heterophoria, and 
fusional vergence values in MS patients.
An association between ON and MS has been 
widely described by other authors, with most patients 
suffering a decrease in visual pathways,10–13 but there 
have been no studies analyzing specifically the impact 
of such decreases on binocular vision. The current 
study reports binocular vision parameters in patients 
with MS with and without ON and compares these 
results with those obtained in healthy subjects. The 
percentage of eyes with alterations was also reported 
and compared between groups, considering the norma-
tive data from previous peer-reviewed literature. The 
final aim was to confirm if binocular vision was altered 
more in subjects with MS than controls and if this 
alteration were more pronounced in patients with 
monocular or binocular ON.
Based on the results of the current series, MS does not 
strictly seem to affect NPC, since no differences were 
present between the studied groups, but there was 
a higher trend in patients with MS, specifically in those 
patients suffering ON in one eye. Also, better results in 
recovery ranges were found in controls than study groups. 
These results suggest that once convergence is decompen-
sated (double vision), MS patients find it harder to recover 
single vision. This situation seemed to be more persistent 
in subjects with binocular ON, and even more so in sub-
jects with monocular ON. In the present study, a reference 
value was selected according to a previous study,18 but any 
other criteria could have been used to classify results as 
normal or not. This criterion was quite strict, since nar-
rower NPC values are considered normal when compared 
with other studies.18,26 The percentage of control subjects 
showing abnormal results in the current sample was 26%, 
which is high, but it was even higher when considering 
MS subjects (36%–48%). Regarding the methodology, 
although measurement with an accommodative stimulus 
might be a more appropriate test to determine NPC for 
diagnotic purposes, in the current sample all subjects were 
presbyopes and measured with their best correction for 
near vision, and thus the involvement of accommodation 
in the measurement seems to be quite limited.
Based on the data obtained in the current study, no 
significant differences were found between groups, with 
control subjects showing results consistent with previous 
studies evaluating heterophoria in healthy subjects.19,20 
Table 3 Distribution of Heterophoria Measurements Obtained Using the Cover Test and Modified Thorington Test
Control, n=26 MS, n=27 MSONm, n=19 MSONb, n=11
Cover test Far Orthophoria 22 (88%) 20 (74%) 10 (53%) 4 (40%)
Exophoria 3 (12%) 2 (7.5%) 4 (21%) 4 (40%)
Esophoria — 5 (18.5%) 5 (26%) 3 (20%)
Near Orthophoria 2 (7%) 2 (7.7%) 2 (10.5%) —
Exophoria 18 (70%) 17 (61.5%) 11 (58%) 8 (73%)
Esophoria 6 (23%) 8 (30%) 6 (31.5%) 3 (27%)
Modified Thorington test Far Orthophoria 14 (54%) 8 (30.76%) 7 (37%) 3 (27%)
Exophoria 5 (19%) 10 (38.46%) 3 (16%) 3 (27%)
Esophoria 7 (27%) 9 (30.76%) 9 (47%) 5 (46%)
Near Orthophoria 2 (7.7%) 6 (23%) 6 (31.5%) 2 (18%)
Exophoria 19 (73%) 14 (50%) 6 (31.5%) 5 (46%)
Esophoria 5 (19.3%) 7 (27%) 7 (37%) 4 (36%)
Figure 1 Break and recovery values for negative fusional vergence at near distance 
for all groups in prismatic diopters. Asterisks denote statistically significant differ-
ences between groups.
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However, a trend toward more esophoric results was found 
in patients with MS, specifically in those with monocular 
ON, for near vision, and more markedly on the modified 
Thorington test. The percentage of subjects with abnormal 
heterophoria was higher in MS groups, showing higher 
proportions of esophoria than normal subjects. Although 
there have been no previous studies evaluating the impact 
of ON on heterophorias, the results of the current series 
suggest that patients with ON tend to be more esophoric 
than healthy subjects.
Although the cover test28 and modified Thorington 
test29 have demonstrated good replicability and no statis-
tically significant differences have been reported by other 
authors, these tests cannot be interchangeable.30 Our 
results showed that values obtained with the Thorington 
test were more esophoric for far and near distance than the 
cover test, as has been reported before by other authors 
with healthy subjects,31 perhaps due to the different level 
of dissociation achieved with each method. Future studies 
should be conducted to determine exactly how measure-
ment methodology affects the diagnosis of binocular 
anomalies in subjects with MS.
The results of the current study suggest that no differ-
ences should be expected for positive fusional vergence in 
MS patients compared to healthy subjects in terms of 
break point, recovery point, or range. However, higher 
intrasubject variability was found, perhaps caused by 
patient fatigue15 when measuring vergence several conse-
cutive times or instability of fixation reported in MS 
patients.8,32,33 Regarding divergence fusional ranges, the 
current study found that divergence was affected in all 
subjects with MS, specifically in those with ON in one 
or both eyes. This is consistent with results obtained by 
other authors reporting significant latency in divergence in 
other neurodegenerative diseases, such as Parkinson’s, that 
maintained a convergence fusional range similar to 
controls.34 Furthermore, pontine lesions causing weakness 
of divergence are usually present in demyelinating 
diseases.35 In the current series, although no correlation 
was found between divergence fusional range and near- 
distance heterophoria, more esophoria was found at near 
distance in MS patients, suggesting that alterations in 
divergence can be frequent in these subjects.
Deficits in stereoscopic vision in MS may be due to 
alterations in ocular movements, but also to demyelina-
tion during the disease.9 In the current study, stereopsis 
was lower in all MS patients, but even more so in those 
with ON (especially binocular ON cases). Stereoscopic 
deficiency in MS was consistent with previous studies, 
even when asymptomatic36 and no ON were present,37 
but also stereoscopic deficiency has been found to be 
associated with optic nerve disease.38 Since no 
correlations were found between stereopsis and NPC, 
horizontal heterophoria, or fusional vergence and no 
significant differences found in healthy subjects 
on some binocular parameters, we suggest that stereo-
scopic reduction is caused more by damage in visual 
pathways than in oculomotor control centers, but future 
studies should be conducted to confirm these results.
Conclusion
Negative fusional vergence at near distance and stereopsis 
seem to be the binocular vision parameters affected most 
by MS, becoming worse in patients also suffering ON. In 
Figure 2 Stereoacuity in log arc seconds for all groups. Asterisks denote statistically significant differences between groups.
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addition, the high proportion of esophoria in MS patients 
indicates that more studies are needed for analyzing the 
heterophoria-divergence relationship in these subjects. 
Although NPC and positive fusional vergence did not 
differ significantly between MS and healthy subjects, the 
variability of such parameters suggests a certain level of 
instability that should be investigated.
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